Home | Welcome to Contract Pharma   
Last Updated Wednesday, September 17 2014
Print

Breaking News

Related Searches:
December 21, 2010
Seth V. Hetherington, M.D., senior vice president of Clinical and Regulatory Affairs at Icagen, Inc., will be leaving the company at the end of the year.  Read More »
December 21, 2010
Emisphere Technologies, Inc. and Novo Nordisk have entered into an exclusive development and license agreement to develop and commercialize oral formulations of Novo Nordisk's insulins using Emisphere's Eligen Technology.  Read More »
December 20, 2010
Avila Therapeutics, Inc. has signed a worldwide strategic alliance with Sanofi-Aventis to discover targeted covalent drugs for the treatment of cancers.   Read More »
December 20, 2010
Bristol-Myers Squibb and Oncolys BioPharma, a privately-held biotechnology company based in Japan, have signed a definitive agreement under which BMS will acquire exclusive worldwide rights to manufacture, develop and commercialize festinavir.  Read More »
December 20, 2010
Gilead Sciences has signed an agreement to acquire Arresto Biosciences for $225 million and potential payments based on certain sales levels.  Read More »
December 20, 2010
Onyx Scientific has secured a contract with drug development company Nuformix to become one of its exclusive supply partners for characterization support.   Read More »
December 17, 2010
Commercial manufacturing revenues were flat at $144.8 million in the quarter.  Read More »
December 17, 2010
3M Drug Delivery Systems has signed an exclusive license agreement with Spirig Pharma AG, a Swiss manufacturer of dermatological and dermocosmetic products.   Read More »
December 17, 2010
David Duffield, director of Global Security for Catalent Pharma Solutions has been awarded membership in the American Society for Industrial Security (ASIS), Pharmaceutical Security Council.   Read More »
December 16, 2010
Aesica Pharmaceuticals has entered agreements to acquire three manufacturing sites from UCB, in Monheim and Zwickau, Germany, and Pianezza, Italy.  Read More »
December 16, 2010
Catalyst Biosciences, Inc. has received a $4.0 million milestone payment from Pfizer under their collaboration agreement for the development of recombinant human Factor VIIa variants for the treatment of hemophilia and other bleeding disorders.   Read More »
December 16, 2010
GlaxoSmithKline and Impax Pharmaceuticals entered an agreement for the development and commercialization of IPX066, Impax’s extended release carbidopa-levodopa product, outside the U.S. and Taiwan.  Read More »
December 16, 2010
Galapagos has achieved a $4.7 million milestone in its strategic alliance with Roche.   Read More »
December 15, 2010
Alcon, Inc. has approved a merger agreement with Novartis AG, under which Novartis will pay $12.9 billion for all outstanding Alcon shares.  Read More »
December 15, 2010
Ian Read, Pfizer’s new chief executive officer, has made changes to the company’s executive team.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On